Poly Medicure

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE205C01021
  • NSEID: POLYMED
  • BSEID: 531768
INR
1,388.85
-110.95 (-7.4%)
BSENSE

Feb 06

BSE+NSE Vol: 5.19 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,340.75
1,229.00
997.72
808.38
665.55
573.51
515.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,340.75
1,229.00
997.72
808.38
665.55
573.51
515.91
Raw Material Cost
444.31
429.40
338.17
315.49
268.86
192.33
165.43
Purchase of Finished goods
3.67
5.42
5.66
3.90
5.35
2.18
0.65
(Increase) / Decrease In Stocks
-29.34
-27.54
7.56
-18.36
-27.95
-7.88
-3.51
Employee Cost
279.14
225.11
176.46
149.23
118.42
104.23
103.92
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.01
0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
20.45
15.40
14.06
12.03
13.65
9.37
8.46
Other Expenses
290.92
247.82
194.16
163.91
129.86
113.11
117.15
Total Expenditure (Excl Depreciation)
1,009.16
895.62
736.08
626.20
508.19
413.34
392.10
Operating Profit (PBDIT) excl Other Income
331.59
333.38
261.64
182.18
157.36
160.17
123.81
Other Income
102.32
64.82
43.78
27.69
29.70
11.74
13.24
Operating Profit (PBDIT)
433.91
398.20
305.42
209.87
187.06
171.91
137.05
Interest
11.88
9.83
8.18
6.49
2.81
10.34
10.23
Exceptional Items
-6.80
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
415.23
388.37
297.24
203.38
184.25
161.57
126.82
Depreciation
76.95
61.61
47.73
42.38
39.96
34.98
31.04
Profit Before Tax
339.96
328.48
250.23
161.35
144.81
126.60
95.76
Tax
86.56
82.95
61.91
41.86
36.12
31.21
23.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
251.71
243.81
187.62
119.13
108.17
95.39
72.16
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
251.71
243.81
187.62
119.13
108.17
95.39
72.16
Share in Profit of Associates
3.98
2.91
2.29
1.34
2.17
1.64
1.07
Minority Interest
-0.08
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
255.85
246.72
189.91
120.47
110.34
97.03
73.23
Equity Capital
50.68
50.66
47.97
47.95
47.95
44.12
44.12
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
6.99
8.48
6.77
5.2
3.6
3.99
2.83
Operating Profit Margin (Excl OI)
24.73%
27.13%
26.22%
22.54%
23.64%
27.93%
24.0%
Gross Profit Margin
30.97%
31.6%
29.79%
25.16%
27.68%
28.17%
24.58%
PAT Margin
18.77%
19.84%
18.8%
14.74%
16.25%
16.63%
13.99%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 9.09% vs 23.18% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 3.70% vs 29.91% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is -0.54% vs 27.42% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 20.85% vs 20.17% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Poly Medicure With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,340.75
2,702.20
-1,361.45
-50.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,340.75
2,702.20
-1,361.45
-50.38%
Raw Material Cost
444.31
687.90
-243.59
-35.41%
Purchase of Finished goods
3.67
0.00
3.67
(Increase) / Decrease In Stocks
-29.34
-2.40
-26.94
-1,122.50%
Employee Cost
279.14
804.10
-524.96
-65.29%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
20.45
0.00
20.45
Other Expenses
290.92
597.50
-306.58
-51.31%
Total Expenditure (Excl Depreciation)
1,009.16
2,087.10
-1,077.94
-51.65%
Operating Profit (PBDIT) excl Other Income
331.59
615.10
-283.51
-46.09%
Other Income
102.32
48.50
53.82
110.97%
Operating Profit (PBDIT)
433.91
663.60
-229.69
-34.61%
Interest
11.88
36.70
-24.82
-67.63%
Exceptional Items
-6.80
-70.60
63.80
90.37%
Gross Profit (PBDT)
415.23
556.30
-141.07
-25.36%
Depreciation
76.95
341.40
-264.45
-77.46%
Profit Before Tax
339.96
214.90
125.06
58.19%
Tax
86.56
46.10
40.46
87.77%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
251.71
168.80
82.91
49.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
251.71
168.80
82.91
49.12%
Share in Profit of Associates
3.98
0.00
3.98
Minority Interest
-0.08
0.00
-0.08
Other related items
0.00
0.00
0.00
Consolidated Net Profit
255.85
168.80
87.05
51.57%
Equity Capital
50.68
402.90
-352.22
-87.42%
Face Value
5.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
30.97%
20.59%
0.00
10.38%
PAT Margin
18.77%
6.25%
0.00
12.52%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,340.75 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 9.09% vs 23.18% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 255.85 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 3.70% vs 29.91% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 331.59 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -0.54% vs 27.42% in Dec 2024

Nine Monthly - Interest
Interest 11.88 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 20.85% vs 20.17% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.73%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024